Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities – is there an optimal dose?
Year: 2017
Type: article
Source: Expert Review of Hematology
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Lymphoma Research Foundation
Award: G7088612865
OpenAlex ID: W2728057334
